CD8A and melanoma: Initial reports demonstrated that the isolation and expansion of CD8+ melanoma TILs based on either PD-1, or a combination of PD-1 TIM-3 and LAG-3 expression consistently enriched for T cells recognizing tumors and neoantigens (111, 126).